Dialysis Modalities and HDL Composition and Function

被引:77
作者
Holzer, Michael [1 ]
Schilcher, Gernot [2 ]
Curcic, Sanja [1 ]
Trieb, Markus [1 ]
Ljubojevic, Senka [3 ]
Stojakovic, Tatjana [4 ]
Scharnagl, Hubert [4 ]
Kopecky, Chantal M. [5 ]
Rosenkranz, Alexander R. [2 ]
Heinemann, Akos [1 ]
Marsche, Gunther [1 ]
机构
[1] Med Univ Graz, Inst Expt & Clin Pharmacol, Univ Pl 4, A-8010 Graz, Austria
[2] Med Univ Graz, Clin Div Nephrol, Dept Internal Med, A-8010 Graz, Austria
[3] Med Univ Graz, Clin Div Cardiol, Dept Internal Med, A-8010 Graz, Austria
[4] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8010 Graz, Austria
[5] Med Univ Vienna, Clin Div Nephrol & Dialysis, Dept Internal Med 3, Vienna, Austria
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2015年 / 26卷 / 09期
基金
奥地利科学基金会;
关键词
HIGH-DENSITY-LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; STAGE RENAL-DISEASE; ANTIINFLAMMATORY PROPERTIES; PERITONEAL-DIALYSIS; IN-VITRO; HEMODIALYSIS; LDL; ATHEROSCLEROSIS;
D O I
10.1681/ASN.2014030309
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Lipid abnormalities may have an effect on clinical outcomes of patients on dialysis. Recent studies have indicated that HDL dysfunction is a hallmark of ESRD. In this study, we compared HDL composition and metrics of HDL functionality in patients undergoing hemodialysis (HD) or peritoneal dialysis (PD) with those in healthy controls. We detected a marked suppression of several metrics of HDL functionality in patients on HD or PD. Compositional analysis revealed that HDL from both dialysis groups shifted toward a more proinflammatory phenotype with profound alterations in the lipid moiety and protein composition. With regard to function, cholesterol efflux and anti-inflammatory and antiapoptotic functions seemed to be more severely suppressed in patients on HD, whereas HDL-associated paraoxonase activity was lowest in patients on PD. Quantification of enzyme activities involved in HDL metabolism suggested that HDL particle maturation and remodeling are altered in patients on HD or PD. In summary, our study provides mechanistic insights into the formation of dysfunctional HDL in patients with ESRD who are on HD or PD.
引用
收藏
页码:2267 / 2276
页数:10
相关论文
共 61 条
  • [21] Uremia Alters HDL Composition and Function
    Holzer, Michael
    Birner-Gruenberger, Ruth
    Stojakovic, Tatjana
    El-Gamal, Dalia
    Binder, Veronika
    Wadsack, Christian
    Heinemann, Akos
    Marsche, Gunther
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (09): : 1631 - 1641
  • [22] Protein Carbamylation Renders High-Density Lipoprotein Dysfunctional
    Holzer, Michael
    Gauster, Martin
    Pfeifer, Thomas
    Wadsack, Christian
    Fauler, Guenter
    Stiegler, Philipp
    Koefeler, Harald
    Beubler, Eckhard
    Schuligoi, Rufina
    Heinemann, Akos
    Marsche, Gunther
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2011, 14 (12) : 2337 - 2346
  • [23] The inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice
    Hu, Miao-miao
    Zhang, Jie
    Wang, Wen-yi
    Wu, Wen-yu
    Ma, Yan-ling
    Chen, Wei-hai
    Wang, Yi-ping
    [J]. ACTA PHARMACOLOGICA SINICA, 2011, 32 (10) : 1253 - 1258
  • [24] Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB
    Joergl, Almut
    Platzer, Barbara
    Taschner, Sabine
    Heinz, Leonhard X.
    Hoecher, Bernhard
    Reisner, Peter M.
    Goebel, Florian
    Strobl, Herbert
    [J]. BLOOD, 2007, 109 (01) : 185 - 193
  • [25] The ability of HDL to inhibit VCAM-1 expression and oxidized LDL uptake is impaired in renal patients
    Jurek, Aleksandra
    Turyna, Bohdan
    Kubit, Piotr
    Klein, Andrzej
    [J]. CLINICAL BIOCHEMISTRY, 2008, 41 (12) : 1015 - 1018
  • [26] A biochemical fluorometric method for assessing the oxidative properties of HDL
    Kelesidis, Theodoros
    Currier, Judith S.
    Huynh, Diana
    Meriwether, David
    Charles-Schoeman, Christina
    Reddy, Srinivasa T.
    Fogelman, Alan M.
    Navab, Mohamad
    Yang, Otto O.
    [J]. JOURNAL OF LIPID RESEARCH, 2011, 52 (12) : 2341 - 2351
  • [27] Diminished Antioxidant Activity of High-Density Lipoprotein-Associated Proteins in Chronic Kidney Disease
    Kennedy, David J.
    Tang, W. H. Wilson
    Fan, Yiying
    Wu, Yuping
    Mann, Shirley
    Pepoy, Michael
    Hazen, Stanley L.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (02): : e000104
  • [28] Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
    Khera, Amit V.
    Cuchel, Marina
    de la Llera-Moya, Margarita
    Rodrigues, Amrith
    Burke, Megan F.
    Jafri, Kashif
    French, Benjamin C.
    Phillips, Julie A.
    Mucksavage, Megan L.
    Wilensky, Robert L.
    Mohler, Emile R.
    Rothblat, George H.
    Rader, Daniel J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (02) : 127 - 135
  • [29] Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities
    Kontush, Anatol
    Chapman, M. John
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2010, 21 (04) : 312 - 318
  • [30] Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease
    Kotani, Kazuhiko
    Kimura, Satoshi
    Gugliucci, Alejandro
    [J]. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2011, 67 (03) : 437 - 441